Skip to content
Clinical Trials for Alzheimer's Disease

Missouri

Alzheimer's disease clinical trials in Missouri

29 Alzheimer's disease studies are recruiting participants at sites in 5 cities across Missouri as of November 16, 2026, according to ClinicalTrials.gov.

Call (888) 927-5895
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every Missouri city with a recruiting study

St Louis (25), Bolivar (2), Chesterfield (1), Columbia (1), Kansas City (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Recently updated studies in Missouri

Basic details from each study's public record (the 12 most recently updated of 29). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

    • Phase 3
    • Ages 50 to 90
    • All sexes
    Sponsor
    Hoffmann-La Roche
    Recruiting in
    St Louis
    Registry record
    NCT07177352 · updated
  2. GAPcareAD: A Brief Emergency Department Intervention to Address Post-Fall Care Needs of Persons Living With Dementia and Care Partners

    • No phase
    • Ages 65 and older
    • All sexes
    Sponsor
    University of Colorado, Denver
    Recruiting in
    St Louis
    Registry record
    NCT07563270 · updated
  3. ACP-204 in Adults With Alzheimer's Disease Psychosis

    • Phase 2/3
    • Ages 55 to 95
    • All sexes
    Sponsor
    ACADIA Pharmaceuticals Inc.
    Recruiting in
    St Louis
    Registry record
    NCT06159673 · updated
  4. A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

    • Phase 2
    • Ages 55 to 85
    • All sexes
    Sponsor
    Eli Lilly and Company
    Recruiting in
    Bolivar
    Registry record
    NCT07589595 · updated
  5. A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

    • Phase 3
    • Ages 55 and older
    • All sexes
    Sponsor
    Eli Lilly and Company
    Recruiting in
    Bolivar
    Registry record
    NCT07602582 · updated
  6. A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

    • Phase 3
    • Ages 55 to 90
    • All sexes
    Sponsor
    Karuna Therapeutics, Inc., a Bristol Myers Squibb company
    Recruiting in
    St Louis
    Registry record
    NCT06585787 · updated
  7. A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)

    • Phase 4
    • Ages 50 and older
    • All sexes
    Sponsor
    Alpha Cognition, Inc
    Recruiting in
    St Louis
    Registry record
    NCT07633470 · updated
  8. A Study to Evaluate Mivelsiran in Adult Participants With Early-Stage Down Syndrome-Associated Alzheimer's Disease (DS-AD)

    • Phase 2
    • Ages 40 to 55
    • All sexes
    Sponsor
    Alnylam Pharmaceuticals
    Recruiting in
    St Louis
    Registry record
    NCT07636811 · updated
  9. Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease

    • Phase 2
    • Ages 55 to 80
    • All sexes
    Sponsor
    Lighthouse Pharmaceuticals, Inc.
    Recruiting in
    Chesterfield
    Registry record
    NCT06847321 · updated
  10. Dominantly Inherited Alzheimer Network (DIAN)

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    Washington University School of Medicine
    Recruiting in
    St Louis
    Registry record
    NCT00869817 · updated
  11. Study to Understand Novel Biomarkers in Researching Dementia

    • Observational
    • Ages 60 and older
    • All sexes
    Sponsor
    Washington University School of Medicine
    Recruiting in
    St Louis
    Registry record
    NCT06547099 · updated
  12. Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    Eidos Therapeutics, a BridgeBio company
    Recruiting in
    Kansas City · St Louis
    Registry record
    NCT06563895 · updated

Source: ClinicalTrials.gov. Data processed . See every Alzheimer's disease study recruiting in Missouri on ClinicalTrials.gov.

Ask about studies in Missouri

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Clinical Trials for Alzheimer's Disease does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-5895

or send a short form

How should we reach you?

Call